TikTok Influencers Fueling Parallel Market for Unlicensed Weight-Loss Drug

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before directing buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals administering substances of uncertain source.

Some professionals said the popularity for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Service Reaction and Content Removal

Based on the social media company, the service has taken down problematic material and prohibited associated hashtags and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to nine thousand members selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or injecting at home.

Within minutes of entering one group, a seller posted WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, medical conditions or previous experience.

Item Information and Costs

Inside these communities, posts show black plastic packages with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it actively monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they can’t verify. Even if the science behind this drug is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously seen individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to possibly significant health risks”.